Sacral Neuromodulation in Patients With Double Incontinence
- Sponsor
- University Hospital Ostrava
- Study ID
- NCT07212387
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Double Incontinence
- Faecal Incontinence
- Urinary Incontinence
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sacral neurostimulation — PROCEDURESacral neurostimulation (SNS), or sacral neuromodulation (SNM), is a minimally invasive, reversible treatment for bladder and bowel control problems, including overactive bladder and fecal incontinence.
Study Details
This is a prospective study evaluating the effect of a treatment method of sacral neuromodulation (SNM), the use of which is approved and recommended for the treatment of both faecal incontinence (FI) and urinary incontinence (UI). A new aspect of the study is monitoring the effect of SNM in patients with both types of incontinence (faecal and urinary) occurring simultaneously. The study will use diagnostic methods and procedures that are part of the usual examination algorithm. The study will not impose any burden on patients beyond the scope of routine examination and treatment procedures.
Key Dates
- First listed
- Oct 8, 2025
- Start date
- Nov 30, 2025
- Status verified
- Sep 2025
- Primary completion
- Nov 30, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Sacral neuromodulationFemale patients with double incontinence (DI) will be enrolled into this study group. The study subjects will undergo sacral neurostimulation (SNM).
Primary Outcome Measure
Overall effect of SNM [ Time Frame: 18 months ]
Central Contacts
- Jiří Hynčica0042059737
Related Studies
- Muscle Fiber Fragment Treatment for Urinary IncontinencePHASE1/PHASE2 · Recruiting · Wake Forest University · Winston-Salem, North Carolina
- Adjustable Continence Therapy (ACT) for the Treatment of Female SUIRecruiting · Uromedica · Denver, Colorado
- Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord InjuriesPHASE2 · Recruiting · The University of Texas Medical Branch, Galveston · Galveston, Texas
- Feasibility of Triggered Sacral Neuromodulation for Neurogenic BladderRecruiting · VA Office of Research and Development · Cleveland, Ohio